secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001140361-23-047516
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Health prelim Q3 revenue $4.7-4.9M, up 13-18% YoY
----------------------------------------------------------

- Preliminary Q3 2023 revenue range $4.7M to $4.9M, representing 13-18% growth over Q3 2022.
- UltraMist product line revenue increased >25% YoY and >10% sequentially vs Q2 2023.
- UltraMist accounted for >90% of total revenue in the quarter.
- Production constraints easing contributed to revenue growth; full Q3 results expected mid-November.
- No other financial metrics (EPS, net income) disclosed; numbers remain preliminary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123047516/0001140361-23-047516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123047516/ef20012207_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-047516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer